Navigation Links
US Neuropathic Pain Market Value Doubles to $5 Billion by 2018
Date:9/11/2008

New Indications and Products Offset Patent Expirations

SAN FRANCISCO, Sept. 11 /PRNewswire/ -- The U.S. market for drug treatment of major neuropathic pain (NP) conditions is currently valued at $2.6 billion, according to US Neuropathic Pain, a report released today by WWMR, Inc. Growth over the past four years has been driven largely by the successful launch of Lyrica (pregabalin) for diabetic neuropathic pain and post-herpetic neuralgia in December 2004 along with its 2007 approval for fibromyalgia, as well as the launch of Lilly's Cymbalta (duloxetine) for diabetic neuropathic pain in 2004. The additional June 2008 approval of Cymbalta for fibromyalgia will spur penetration of this prevalent condition.

Based on a decade of experience tracking and forecasting the NP Market, WWMR predicts healthy growth over the next 5 years due to penetration of the market for fibromyalgia. Two yet to be launched products, Forest Laboratories/Cypress Biosciences's antidepressant milnacipran and Schwarz Pharma's sodium ion channel antagonist/CRMP2 modulator lacosamide (Vimpat), will compete for market share as well as provide the benefit of an additional mechanism of action. Growth will slow between 2013 and 2018 as Lyrica and Cymbalta patents expire, and the fibromyalgia market penetration becomes saturated. Additional launch of novel compounds and new brands of existing drug classes will be required in order to sustain market growth.

The US neuropathic pain market consists of 4.7 million patients, and is expected to grow to more than 6.1 million patients, and be valued at $5.1 billion in 2018. With the addition of two key new indications to this report (Fibromyalgia and Neuropathic Cancer Pain) patient population estimates and projections as well as market value and projections, are available for a total of ten Neuropathic Pain Conditions (neuropathic back pain, fibromyalgia, diabetic neuropathy, neuropathic cancer pain, complex regional pain sy
'/>"/>

SOURCE WWMR, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Aegera initiates Phase 1 clinical trial of AEG33773 - A small molecule in development for diabetic neuropathic pain
2. Reminder: XTL to Hold a Conference Call Today at 8:30 am EDT to Discuss the Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
3. XTL Biopharmaceuticals Initiates Phase IIb Clinical Trial of Bicifadine for the Treatment of Diabetic Neuropathic Pain
4. US Facet Fixation Market to Increase by Over 60% Annually Through 2012
5. Biotechnology & Drug Discovery Markets Push Up Demand for Lab Automation Products, According to a New Report by Global Industry Analysts
6. Injectable CTM Manufacturing Market Report Now Available
7. Eyeforpharmas Marketing Summit is shaping up to be the biggest event of its kind ever
8. SectorWatch.biz Issues MarketStats on Agri-Biotech Equities YGYB, GRO, SEED, MON, ADM, and BG
9. Filter Markets - Discover the Growth Segments
10. China Sky One Medical, Inc. Approved to List on the NASDAQ Global Market
11. CoreValve Successfully Treats the First Pacific Rim Patients with Its ReValving System for Percutaneous Aortic Valve Replacement : Australia/New Zealand Regulatory-Cleared Evaluation Registry is Expected to Lead to Market Clearance for These Countries

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...e-FirstCall/ -- Inverness Medical Innovations, Inc...viduals to take charge of their health at home thr...nagement, has declared a dividend of $3.00 per sha... Stock ( IMA-PB). The dividend will be paid in sha... to the quotient of (a) $3.00 divided by (b) 97% o...
(Date:12/2/2009)...e-FirstCall/ -- Martek Biosciences Corporation (Na...elease the results of its fourth quarter and fisca... 4:00 p.m. Eastern Time (ET). Following the relea...ce call to discuss these results with investors. ... via webcast by visiting Martek,s web site at htt...
(Date:12/2/2009)...e/ -- Reportlinker.com announces that a new market..., Carbondioxide Incubators - A Global Market Pe...4368/Carbondioxide-Incubators---A-Global-Market-Pe...tical equipment used in microbiology, genetics, ca...ng a controlled environment to grow and store biol...
(Date:12/2/2009)...- The world,s first concept demonstration tires ...lternative to replace a petrochemically produced i...ith renewable biomass, made their debut in Copenha...ay at a lounge in the common departure area at the...ber 21, while the other tire will make appearances...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
...ase I/II trial TSX symb... - SemBioSys Genetics Inc.,(TSX: SBS), a biotechno...,proteins for metabolic and cardiovascular disease...ogy study in animals to demonstrate the safety and...o pharmaceutical grade,human insulin. This study i...
...PRNewswire-FirstCall/,-- Evotec AG (Frankfurt Stoc... WKN 566480) announced today that the U.S. Securit...ective Evotec,s Registration Statement on,Form F-4...er transaction,with Renovis, Inc., a South San Fra...the discovery and development of drugs for major m...
...der of,ion channel testing services for drug-disco... the SBS conference the company,s expanding,line o...very researchers,the early information they need t...ate those that could be harmful -- before they inv...14th Annual Society for Biomolecular,Sciences (SBS...
Other Biology Technology:SemBioSys initiates toxicology study for safflower-produced insulin 2SemBioSys initiates toxicology study for safflower-produced insulin 3Evotec's Registration Statement in Connection With its Proposed Acquisition of Renovis Declared Effective 2Evotec's Registration Statement in Connection With its Proposed Acquisition of Renovis Declared Effective 3ChanTest to Highlight Most-Comprehensive Range of Ion Channel Profiling Screens and Consultation Services at 14th Annual SBS Conference, Booth 1104 2ChanTest to Highlight Most-Comprehensive Range of Ion Channel Profiling Screens and Consultation Services at 14th Annual SBS Conference, Booth 1104 3
(Date:12/3/2009)... that occurred during the 2008-09 austral summer w... for two main climate drivers, ENSO (El Nio - Sout...ular Mode), according to Dr. Marco Tedesco, Assist...he City College of New York. , Professor Tedes...Y Graduate Center, added that Antarctic snowmelt l...
(Date:12/2/2009)...st cigarette within minutes after waking up have m...otine when processed by the body, than those who w...es smoked. , "Since cotinine levels appear to...est that smokers who smoke immediately after wakin... researcher Joshua E. Muscat, Ph.D., M.P.H., profe...
(Date:12/2/2009)... other foods have done more than raise public awar... quietly fueling a boom in the market for food tes...ations. That,s the topic of the two-part cover sto... News , (C&EN) ACS, weekly newsmagazine. , C&EN ...pondent Marc Reisch point out that food safety is ...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Increased nicotine levels detected in those who light-up earlier 2Hearing Aid Savings Galore 52907 1Hearing Aid Savings Galore 52907 2Houston Northwest Medical Centers Bariatric Program Rated Top 15 25 in the Nation by HealthGrades 52902 1Houston Northwest Medical Centers Bariatric Program Rated Top 15 25 in the Nation by HealthGrades 52902 2Houston Northwest Medical Centers Bariatric Program Rated Top 15 25 in the Nation by HealthGrades 52902 3Plain White Ts to Headline Lake Effect Benefit for Rainbow Hospice and Palliative Care at Palmer House Friday August 28th 52898 1Plain White Ts to Headline Lake Effect Benefit for Rainbow Hospice and Palliative Care at Palmer House Friday August 28th 52898 2Plain White Ts to Headline Lake Effect Benefit for Rainbow Hospice and Palliative Care at Palmer House Friday August 28th 52898 3
...th may owe its existence to tiny microorganisms li...d change on the vital services these microbes perf... a report released today by the American Academy o...y: The Key to Earth,s Habitability. , "Since life ...isms are the closest living descendants of the ori...
...herapy has been used to suppress HIV replication a...f disease in affected patients. But the existence...ation of HIV from treated patients. In a new study...l Investigation, Tae-Wook Chun and colleagues from... HIV in infected individuals receiving antiviral t...
...thora of dog genome-related materials are publishe...Genome and a series of primary research articles ...ons, concomitant with the publication by Nature ..., are expected to provide both researchers and the...nomics and biology. , "Canine genetics has entered...
Other Biology News:Understanding the oceans microbes is key to the Earth's future 2Dog genome sequenced 2Dog genome sequenced 3Dog genome sequenced 4
Fingerprinting II Database Sharing Tools from Bio-Rad
Fingerprinting II Informatix Dimensioning Techniques from Bio-Rad
Fingerprinting II Comparative Quantification and Polymorphism Analysis from Bio-Rad
DNA Engine Dyad Thermal Cycler Chassis, w/2 x 384-well blocks from Bio-Rad
Biology Products: